Overview
- Eli Lilly announced a new medicines production facility in Katwijk’s Zijlhoek–De Woerd with an investment reported as about €2.6 billion by FD and roughly $3 billion by provincial officials.
- The reserved site spans roughly 15 hectares near Leiden Bio Science Park, with the project positioned alongside planned housing expansion of about 1,200 homes.
- Officials say the build will generate about 1,500 construction jobs and roughly 500 permanent roles once production starts.
- The company and government partners stress the plan is an initial step that requires municipal and environmental permits and solutions for local grid congestion and nitrogen limits, with hopes to start construction next year.
- FD reports the plant is slated to produce Lilly’s new weight-loss pill, and CEO Dave Ricks used the announcement to fault Europe and the Netherlands for slow approvals and low prices, warning research will shift away.